Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natural antisense transcripts (NATs) are RNA molecules transcribed from the DNA strand opposite to a protein-coding or non-coding gene. The "novel transcript, antisense to RASL11B" refers to an RNA produced from the DNA region opposite to RASL11B (RAS like family 11 member B). NATs can regulate the expression of their sense gene counterparts through mechanisms such as RNA masking, transcriptional interference, double-stranded RNA-dependent pathways, and chromatin remodeling. There is no specific functional characterization, disease association, or pharmacological relevance reported for this particular NAT. Its name and accession (ENSG00000305969, LOC124900700) denote a predicted or computationally annotated transcript without validated function, standard abbreviation, or known involvement in human pathology or therapeutics. RASL11B itself is a small GTPase implicated in GTP binding and possibly negative regulation of TGF-beta signaling, but the antisense transcript does not code for the RASL11B protein. Natural antisense transcripts in general can influence mRNA splicing, stability, or translation of the sense gene, but such effects for this specific NAT are unreported and must be considered speculative. This "target" is not druggable and does not fall into recognized categories such as receptor, enzyme, transporter, or transcription factor. This entry likely represents an automatically annotated, unstudied RNA and should not be considered a canonical therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natural antisense transcript to RAS like family 11 member B.